Page last updated: 2024-12-07

5-hydroxymethyl-2-furoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-Hydroxymethyl-2-furoic acid, also known as 5-hydroxymethylfuran-2-carboxylic acid, is a naturally occurring compound found in various plant species, including asparagus, onions, and garlic. It exhibits a range of biological activities, including antioxidant, anti-inflammatory, and anti-cancer effects. The compound has been studied extensively for its potential therapeutic applications. One area of interest is its ability to modulate the immune response. Studies have shown that 5-hydroxymethyl-2-furoic acid can suppress the production of pro-inflammatory cytokines and promote the differentiation of regulatory T cells, which play a role in immune tolerance. Furthermore, this compound has been investigated for its potential as a neuroprotective agent. Research suggests that 5-hydroxymethyl-2-furoic acid can protect neurons from damage induced by oxidative stress and amyloid-beta aggregation, both of which are implicated in neurodegenerative diseases such as Alzheimer's disease. In addition to its biological activities, 5-hydroxymethyl-2-furoic acid has also been explored for its potential use as a building block in the synthesis of various pharmaceuticals and agrochemicals. Its unique structural features, particularly the presence of a furan ring and a hydroxyl group, make it a valuable starting material for the development of novel compounds with desired properties. Various synthetic routes have been developed for the preparation of 5-hydroxymethyl-2-furoic acid, including the oxidation of furfuryl alcohol and the condensation of furfural with glyoxylic acid.'

5-hydroxymethyl-2-furoic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5-hydroxymethyl-2-furoic acid : A member of the class of furoic acids that is 2-furoic acid substituted at position 5 by a hydroxymethyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID80642
CHEMBL ID468037
CHEBI ID89118
SCHEMBL ID50822
MeSH IDM0511372

Synonyms (71)

Synonym
HMS1681G08
BB 0256593
5-hydroxymethyl-furan-2-carboxylic acid
BAS 00404252
nsc-40739
5-hydroxymethyl-2-furancarboxylic acid ,
2-furoic acid, 5-(hydroxymethyl)-
6338-41-6
nsc40739
5-hydroxymethyl-2-furoic acid
2-furancarboxylic acid, 5-(hydroxymethyl)-
sumiki's acid
OPREA1_060549
OPREA1_518608
5-(hydroxymethyl)-2-furoic acid
NCGC00091546-01
inchi=1/c6h6o4/c7-3-4-1-2-5(10-4)6(8)9/h1-2,7h,3h2,(h,8,9
EC-000.1550
STK256640
5-(hydroxymethyl)furan-2-carboxylic acid
AKOS000505137
chebi:89118 ,
CHEMBL468037
BBL015780
A834352
EN300-91706
NCGC00091546-03
NCGC00091546-02
unii-ji63td4992
ji63td4992 ,
nsc 40739
NCGC00260669-01
tox21_201082
dtxsid5033098 ,
cas-6338-41-6
dtxcid3013098
C20448
5-hydroxymethyl-2-furoate
5-hydroxymethyl-2-furanoic acid
FT-0636101
AM20100567
GEO-03105
S6081
SCHEMBL50822
H1750
hmfca
5-hydroxymethylfuran-2-carboxylic acid
5-hydroxymethylfurancarboxylic acid
5-hydroxymethyl-2-furan-carboxylic acid
AC-22968
5-hydroxymethylfuroic acid
5-hydroxymethylfuranoic acid
J-517613
5-hydroxymethyl-2-furancarboxylic acid, aldrichcpr
CS-W005241
mfcd03274472
5-hydroxymethyl-2-furancarboxylate
5-(hydroxymethyl)-2-furoate
5-hydroxymethylfuranoate
5-hydroxymethylfuroate
5-hydroxymethyl-furan-2-carboxylate
5-(hydroxymethyl)- 2-furancarboxylate
HY-W005241
BCP25291
Q27161297
SY062854
AS-18462
SB38045
5-hydroxymethyl-2-furancarboxylicacid
sumikis' acid
Z385458092
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
human urinary metaboliteAny metabolite (endogenous or exogenous) found in human urine samples.
nematicideA substance used to destroy pests of the phylum Nematoda (roundworms).
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
furoic acidA monocarboxylic acid that consists of a furan ring having a single carboxylic acid group on any ring position and derivatives thereof.
aromatic primary alcoholAny primary alcohol in which the alcoholic hydroxy group is attached to a carbon which is itself bonded to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency12.58930.004023.8416100.0000AID485290
pregnane X receptorRattus norvegicus (Norway rat)Potency50.11870.025127.9203501.1870AID651751
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.20890.006038.004119,952.5996AID1159521; AID1159523
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency8.79320.000323.4451159.6830AID743065
Nuclear receptor ROR-gammaHomo sapiens (human)Potency74.97800.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID355895Antioxidant activity assessed as DPPH radical scavenging activity at 50 ug/mL2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID355903Antifungal activity against Microbotryum violaceum 50 ug/disk by agar diffusion method2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID355896Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug/mL2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID355901Antibacterial activity against Escherichia coli 50 ug/disk by agar diffusion method2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID355892Antioxidant activity assessed as inhibition of peroxidation of linolenic acid at 7.4 ug/mL by TBARS assay2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID359749Antibacterial activity against Escherichia coli ATCC 25922 at 5 ug after 24 hrs by agar plate diffusion assay2001Journal of natural products, Apr, Volume: 64, Issue:4
New macrolides and furan carboxylic acid derivative from the sponge-derived fungus Cladosporium herbarum.
AID355950Antioxidant activity assessed as DPPH radical scavenging activity at 500 ug/mL2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID1651643Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production preincubated for 3 hrs followed by LPS-stimulation and measured after 24 hrs by Griess reagent based assay2020Journal of natural products, 04-24, Volume: 83, Issue:4
Anti-inflammatory Metabolites from
AID355906Antimicrobial activity against Chlorella fusca 50 ug/disk by agar diffusion method2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID355893Antioxidant activity assessed as inhibition of peroxidation of linolenic acid at 37 ug/mL by TBARS assay2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID359747Antibacterial activity against Bacillus subtilis 168 at 5 ug after 24 hrs by agar plate diffusion assay2001Journal of natural products, Apr, Volume: 64, Issue:4
New macrolides and furan carboxylic acid derivative from the sponge-derived fungus Cladosporium herbarum.
AID359748Antibacterial activity against Staphylococcus aureus ATCC 25923 at 5 ug after 24 hrs by agar plate diffusion assay2001Journal of natural products, Apr, Volume: 64, Issue:4
New macrolides and furan carboxylic acid derivative from the sponge-derived fungus Cladosporium herbarum.
AID355902Antibacterial activity against Bacillus megaterium 50 ug/disk by agar diffusion method2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID355899Inhibition of HIV1 reverse transcriptase assessed as residual enzyme activity at 66 ug/mL2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID359750Antifungal activity against Candida albicans at 5 ug after 24 hrs by agar plate diffusion assay2001Journal of natural products, Apr, Volume: 64, Issue:4
New macrolides and furan carboxylic acid derivative from the sponge-derived fungus Cladosporium herbarum.
AID355897Inhibition of p56-LCK assessed as residual enzyme activity at 200 ug/mL2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID355905Antifungal activity against Mycotypha microspora 50 ug/disk by agar diffusion method2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID355894Antioxidant activity assessed as DPPH radical scavenging activity at 25 ug/mL2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID355904Antifungal activity against Eurotium repens 50 ug/disk by agar diffusion method2003Journal of natural products, May, Volume: 66, Issue:5
Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (35.71)29.6817
2010's6 (42.86)24.3611
2020's3 (21.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.85 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index40.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]